Pharma Journalist - Page 773 of 923 -

MSD Completes $5.8 Billion Terns Pharmaceuticals Acquisition

Madrigal Licenses Gene Therapy Candidate for MASH Treatment

Citius Oncology Secures $36.5M to Boost LYMPHIR Launch

Concert Pharmaceuticals proclaims facilitation of Candidate CTP-692 in Schizophrenia

FDA finalizes Booz Allen for Spot on $300M Award to optimize DRM

Apnea Sciences Corporation launched SnoreRx as approved by FDA

MAIA Pharmaceuticals sought approval by FDA for NDA for Sincalide for injection

BioAtla enlists first patient in Phase 1/2 BA3011-001 Clinical Trial for CAB-AXL-ADC Therapeutic

Sangamo seeks MHRA authorization for CTA for Phase 1/2 Clinical Trial assessing SB-FIX

MabVax Therapeutics affirms positive results from Phase1 Clinical trial reviewing MVT-1075

Second Genome initiates 4 collaborations assessing the effect of gut microbiota